Related Experiment Video
Updated: Aug 12, 2026
08:27
Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
[Present and future of vaccines]
1R & D Center BML Inc., Kawagoe 350-1101.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 25, 2001
Summary
Understanding vaccine development, from history to current challenges like cost and safety, is crucial. New technologies and prophylactic vaccines for diseases like cancer are advancing rapidly.
Area of Science:
- Vaccinology and immunology
- Biotechnology and biopharmaceutical production
- Public health and infectious disease control
Context:
- Current vaccine development faces challenges in efficacy, safety, and cost.
- Regulatory frameworks like the Drugs and Cosmetics Act and Good Manufacturing Practices (GMP) ensure vaccine quality.
- Ongoing research addresses limitations of existing vaccines and production methods.
Purpose:
- To review the history and current status of vaccine development.
- To highlight challenges and areas for improvement in vaccine technology and production.
- To explore emerging vaccine candidates and novel applications.
Summary:
- The review traces vaccine development history, noting existing challenges in efficacy, safety, and cost.
- It details regulatory standards (Drugs and Cosmetics Act, Minimum Requirement of Biological Products, GMP) for vaccine quality.
- Emerging vaccine technologies (DNA vaccines, mucosal vaccines) and applications (cancer, autoimmune diseases) are discussed.
Impact:
- Informs researchers and policymakers about the evolving landscape of vaccine development.
- Highlights the potential of new technologies to address unmet medical needs.
- Provides a foundation for future advancements in prophylactic and therapeutic vaccines.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.